the capacity of sephadex and of chemically substituted sephadex derivatives to activate human complement was examined by incubating polymer particles in normal human serum ( nhs ) under conditions that allow classical and/or alternative pathway activation , and by determining complement consumption or generation of c3a antigen in serum .
C0009498
complement
C0229671
serum